http://bcl.med.harvard.edu/research/projects/nicdep/ Beyond Association: Predictive Modeling of Nicotine Dependence
home about us research people publications
 




  project
    description
    people
    publications
    support
    external links
 

Genomic Predictive Modeling
of Nicotine Dependence

 
description
 
Tobacco use, primarily cigarette smoking, is the greatest source of preventable mortality in the world and costs over $160 million in health-related economic losses in the U.S. alone. Nicotine dependence is the primary reason that smokers continue smoking and that most unassisted quit attempts fail within a single week. It is known that nicotine dependence has a genetic component, but that it is a complex trait, i.e., no single gene is responsible for nicotine dependence. Thus, researchers and funding agencies have devoted considerable effort and support to identifying the genetic underpinnings of the trait through whole genome scans, putting us in a unique position to identify global genetic predictors of nicotine dependence. In collaboration with the Collaborative Genetic Study of Nicotine Dependence (COGEND), this project proposes to identify the set of genetic variations predicting the complex trait of nicotine dependence .
 
people
 
Marco F Ramoni Principal Investigator Harvard Medical School
Rachel B Ramoni Investigator Harvard School of Dental Medicine
Laura Bierut Collaborator Washington University
Jonathan Dreyfuss Researcher Harvard Medical School
 
publications
 
Ramoni RB, Saccone NL, Hatsukami DK, Bierut LJ, Ramoni MF, Genomic Prognostic Modeling of Nicotine Dependence Using Bayesian Networks. [article] [www]
 
support
 
Cutting Edge Basc Research Award (CEBRA), National Institute of Drug Addiction, National Institutes of Health (1R21DA025168-01)
 
external links
 
Website of the Collaborative Genetic Study of Nicotine Dependence (COGEND) [here]